Table 4 Factors associated with index tumor volume > 0.718 in entire cohort and each risk group

OR

95%CI

p-value

OR

95%CI

p-value

PSAD >0.345 vs ≤0.345 ng/ml/cc

3.780

1.520–9.440

0.004

2.860

1.060–7.680

0.038

% positive cores >21.4 vs ≤21.4%

6.640

3.520–12.50

<0.001

5.110

2.660–9.840

<0.001

% dominant side >37.5 vs ≤37.5%

6.140

3.250–11.60

<0.001

% cancer extent >55.6 vs ≤55.6%

3.240

1.790–5.880

<0.001

2.370

1.250–4.520

0.009

NCCN risk high vs intermediate

1.220

0.717–2.070

0.465

OR

95%CI

p-value

OR

95%CI

p-value

PSAD >0.190 vs ≤0.190 ng/ml/cc

2.330

1.190–4.560

0.014

% positive cores >21.4 vs ≤21.4%

8.050

3.320–19.50

<0.001

6.760

2.750–16.70

<0.001

% dominant side >36.4 vs ≤36.4%

5.900

2.610–13.40

<0.001

% cancer extent >57.1 vs ≤57.1%

3.460

1.570–7.650

0.002

2.370

1.010–5.58

0.048

OR

95%CI

p-value

OR

95%CI

p-value

PSAD >0.345 vs ≤0.345 ng/ml/cc

1.950

0.643–5.900

0.239

% positive cores >35.0 vs ≤35.0%

7.380

1.610–33.90

0.010

7.380

1.610–33.90

0.010

% dominant side >40.0 vs ≤40.0%

3.560

1.390–9.100

0.008

% cancer extent >55.6 vs ≤55.6%

2.410

0.959–6.050

0.061